Asarfi Hospital Financials

BSE: 543943

₹183.80

₹-10.05 (-5.18%)

As on 08-Sep-2026IST

Market cap

₹362 Cr

Revenue (TTM)

₹184 Cr

P/E Ratio

20.3

P/B Ratio

3.5

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	183.76	120.57	84.40	--	--	--
Total Income	187.21	128.09	86.07	--	--	--
Total Expenditure	147.61	97.02	68.33	--	--	--
EBITDA	36.15	23.55	16.07	--	--	--
Depreciation	11.70	12.68	8.79	--	--	--
EBIT	24.45	10.87	7.28	--	--	--
Interest	4.19	4.08	2.71	--	--	--
Other Income	3.44	7.52	1.67	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	23.70	14.31	6.24	--	--	--
Provision for Tax	5.90	3.73	2.08	--	--	--
Profit after Tax	17.81	10.58	4.16	--	--	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	17.81	10.58	4.16	--	--	--

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	101.91	80.98	70.41	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	46.92	41.86	39.33	--	--	--
Current Liabilities	51.65	41.04	44.35	--	--	--
Total Liabilities	200.48	163.89	154.09	--	--	--

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	111.29	105.40	108.48	--	--	--
Current Assets	77.11	58.48	45.60	--	--	--
Total Assets	200.48	163.89	154.09	--	--	--
Total Debt*	--	48.56	31.91	--	--	--
Net Current Assets	25.47	17.45	1.25	--	--	--
Contingent Liabilities	--	0.80	0.80	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	-4.35	26.07	--	--	--
Cash Flow from Investing Activities	--	-7.38	-63.19	--	--	--
Cash from Financing Activities	--	12.57	36.41	--	--	--
Net Cash Inflow / Outflow	--	0.84	-0.71	--	--	--

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	9.05	5.37	2.11	--	--	--
Cash EPS (₹)	9.05	11.82	6.58	--	--	--
Adjusted Book Value (₹)	51.79	41.16	35.78	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-2.21	13.25	--	--	--
Free Cash Flow per Share (₹)	--	-7.32	-12.14	--	--	--

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	15.86	8.75	--	--	--
ROE (%)	18.20	13.97	5.91	--	--	--
ROA (%)	9.71	6.65	2.70	--	--	--
EBIT Margin (%)	13.31	9.02	8.62	--	--	--
Net Margin (%)	9.51	8.26	4.84	--	--	--
Cash Profit Margin (%)	--	19.29	15.34	--	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	36.59	42.85	--	--	--	--
EBIT Growth (%)	68.52	49.38	--	--	--	--
Net Profit Growth (%)	45.43	154.14	--	--	--	--
EPS Growth (%)	45.41	154.14	--	--	--	--
Book Value Growth (%)	--	15.02	--	--	--	--

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	20.31	15.43	30.89	--	--	--
Price / Book Value	3.55	2.01	1.83	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	10.31	6.77	9.01	--	--	--
Close Price (₹)	225.25	82.91	65.33	--	--	--
High Price (₹)	256.95	111.95	145.75	--	--	--
Low Price (₹)	117.20	52.84	52.00	--	--	--
Market Cap (₹ Cr)	361.67	163.15	128.55	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	0.34	0.60	0.45	--	--	--
Short term debt to equity ratio	--	0.11	0.14	--	--	--
Current Ratio	1.49	1.43	1.03	--	--	--
Quick Ratio	1.43	1.37	0.99	--	--	--
Interest Coverage	6.65	4.51	3.31	--	--	--

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	35.23	33.01	28.74	--	--	--
Asset Turnover	1.00	0.76	0.55	--	--	--
Receivable days	--	96.96	104.90	--	--	--
Inventory Days	--	6.17	7.78	--	--	--
Payable days	--	248.23	446.49	--	--	--
Cash Conversion Cycle	--	-145.10	-333.80	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)